LBF20207PG53
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1732 |
LipidMaps | LMFA03010050 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG53 |
15S-15-methyl Prostaglandin D2 | |
---|---|
Structural Information | |
(9α,15S) -Dihydroxy-11-oxo-15-methylprosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
Formula | C21H34O5 |
Exact Mass | 366.240624198 |
Average Mass | 366.49166 |
SMILES | C(=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)[C@](C)(O)CCCCC |
Physicochemical Information | |
15(S)-15-methyl Prostaglandin D2 is reported to inhibit ADP-induce human platelet aggregation (IC50 value of 320 ng/ml) and increase systemic blood pressure in rat. Bundy_GL et al.15(S)-15-methyl Prostaglandin D2 shows strong anti-fertility effect in hamster (100% at 50 mu g/hamster). Bundy_GL et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|